The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Recruiting · NCT06111781 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The SUGAR Study; SBRT and Relugolix) for Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-09-14 | NCT06111781 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
| Yale University | 458 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | United States | 86 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 5 |
| University of Washington | Seattle | United States | 36 |
| Yale Cancer Center | New Haven | United States | 31 |